Skip to main navigation Skip to search Skip to main content

Binding of bufuralol, dextromethorphan, and 3,4-methylenedioxymethylamphetamine to wild-type and F120A mutant cytochrome P450 2D6 studied by resonance Raman spectroscopy

  • A. Bonifacio
  • , P.H.J. Keizers
  • , J.N.M. Commandeur
  • , N.P.E. Vermeulen
  • , B. Robert
  • , C. Gooijer
  • , G. van der Zwan

    Research output: Contribution to JournalArticleAcademicpeer-review

    Abstract

    Cytochrome P450 2D6 (CYP2D6) is one of the most important drug-metabolizing enzymes in humans. Resonance Raman data, reported for the first time for CYP2D6, show that the CYP2D6 heme is found to be in a six-coordinated low-spin state in the absence of substrates, and it is perturbed to different extents by bufuralol, dextromethorphan, and 3,4-methylenedioxymethylamphetamine (MDMA). Dextromethorphan and MDMA induce in CYP2D6 a significant amount of five-coordinated high-spin heme species and reduce the polarity of its heme-pocket, whereas bufuralol does not. Spectra of the F120A mutant CYP2D6 suggest that Phe
    Original languageEnglish
    Pages (from-to)772-9
    JournalBiochemical and Biophysical Research Communications
    Volume343
    Issue number3
    DOIs
    Publication statusPublished - 2006

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Binding of bufuralol, dextromethorphan, and 3,4-methylenedioxymethylamphetamine to wild-type and F120A mutant cytochrome P450 2D6 studied by resonance Raman spectroscopy'. Together they form a unique fingerprint.

    Cite this